Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 17.12% is 18% below its 5-year average of 20.76%, near the high end of its 5-year range (-70.76%–34.77%).
13.36% above its 12-month average of 15.10%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 13.29%.
EBITDA MARGIN
17.12%
EBITDA MARGIN AVG TTM
15.10%
EBITDA MARGIN AVG 3Y
20.37%
EBITDA MARGIN AVG 5Y
20.76%
EBITDA MARGIN AVG 10Y
13.50%
EBITDA MARGIN AVG 15Y
6.77%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.36%
CURRENT VS 3Y AVG
-15.97%
CURRENT VS 5Y AVG
-17.53%
CURRENT VS 10Y AVG
+26.81%
CURRENT VS 15Y AVG
+152.93%
CURRENT VS 20Y AVG
N/A
Pacira BioSciences, Inc.
Market Cap
$973.93M
EBITDA Margin
17.12%
TTM Avg
15.10%
3Y Avg
20.37%
5Y Avg
20.76%
Market Cap
$978.09M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
EBITDA Margin
-114.71%
TTM Avg
-284.80%
3Y Avg
-531.58%
5Y Avg
-445.59%
Market Cap
$982.46M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$953.81M
EBITDA Margin
-1113.67%
TTM Avg
-2254.05%
3Y Avg
-2254.05%
5Y Avg
-2254.05%
Market Cap
$952.91M
EBITDA Margin
-19083.66%
TTM Avg
-19083.66%
3Y Avg
-19083.66%
5Y Avg
-24221442.25%
Market Cap
$996.65M
EBITDA Margin
-31.64%
TTM Avg
-36.17%
3Y Avg
-63.38%
5Y Avg
-163.90%
Market Cap
$998.69M
EBITDA Margin
-358.45%
TTM Avg
-358.45%
3Y Avg
-358.45%
5Y Avg
-358.45%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $973.93M | 17.12% | 15.10% | 20.37% | 20.76% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | -114.71% | -284.80% | -531.58% | -445.59% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | N/A | N/A | N/A | N/A |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | N/A | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -1113.67% | -2254.05% | -2254.05% | -2254.05% |
| Savara Inc. (SVRA)vs › | $952.91M | -19083.66% | -19083.66% | -19083.66% | -24221442.25% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -31.64% | -36.17% | -63.38% | -163.90% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -358.45% | -358.45% | -358.45% | -358.45% |
| Immatics N.V. (IMTX)vs › | $1.01B | -351.42% | -184.18% | -130.50% | -161.84% |
Gross Margin
79.2%
EBITDA Margin
17.1%
Operating Margin
2.5%
Net Margin
2.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 13.29% |
| 2026-03-31 | 14.63% |
| 2025-12-31 | 12.46% |
| 2025-09-30 | 15.35% |
| 2025-06-30 | 19.78% |
| 2025-03-31 | 13.71% |
| 2024-12-31 | 24.54% |
| 2024-09-30 | -70.76% |
| 2024-06-30 | 26.46% |
| 2024-03-31 | 18.93% |
| 2023-12-31 | 28.50% |
| 2023-09-30 | 22.06% |
| 2023-06-30 | 34.77% |
| 2023-03-31 | 10.30% |
| 2022-12-31 | 11.93% |
| 2022-09-30 | 24.77% |
| 2022-06-30 | 30.75% |
| 2022-03-31 | 23.69% |
| 2021-12-31 | 10.86% |
| 2021-09-30 | 29.10% |
| 2021-06-30 | 29.31% |
| 2021-03-31 | 20.41% |
| 2020-12-31 | 18.20% |
| 2020-09-30 | 19.29% |
| 2020-06-30 | -2.86% |
| 2020-03-31 | 20.74% |
| 2019-12-31 | 5.56% |
| 2019-09-30 | 4.18% |
| 2019-06-30 | 10.29% |
| 2019-03-31 | 5.12% |
| 2018-12-31 | 17.15% |
| 2018-09-30 | 9.05% |
| 2018-06-30 | 11.16% |
| 2018-03-31 | -5.60% |
| 2017-12-31 | 15.33% |
| 2017-09-30 | -0.31% |
| 2017-06-30 | -17.02% |
| 2017-03-31 | -15.80% |
| 2016-12-31 | 1.10% |
| 2016-09-30 | -25.73% |
| 2016-06-30 | -4.64% |
| 2016-03-31 | 1.39% |
| 2015-12-31 | 3.33% |
| 2015-09-30 | 12.76% |
| 2015-06-30 | 7.78% |
| 2015-03-31 | 10.43% |
| 2014-12-31 | 17.20% |
| 2014-09-30 | 2.70% |
| 2014-06-30 | -1.08% |
| 2014-03-31 | -18.15% |
| 2013-12-31 | -24.19% |
| 2013-09-30 | -49.37% |
| 2013-06-30 | -62.56% |
| 2013-03-31 | -148.56% |
| 2012-12-31 | -137.64% |
| 2012-09-30 | -168.38% |
| 2012-06-30 | -42.30% |
| 2012-03-31 | -125.03% |
| 2011-12-31 | -317.34% |
| 2011-09-30 | -194.74% |
| 2011-06-30 | -234.63% |
| 2011-03-31 | -125.45% |
| 2010-12-31 | -205.11% |
| 2010-09-30 | -120.34% |
| 2010-06-30 | -149.62% |
| 2010-03-31 | -75.31% |
| 2009-12-31 | -151.80% |
| 2009-09-30 | -137.18% |
